Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Prevention of bronchial hyperreactivity in a rat model of precapillary pulmonary hypertension.
Habre W, Albu G, Janosi TZ, Fontao F, von Ungern-Sternberg BS, Beghetti M, Petak F.
Respir Res. 2011 Apr 27;12:58.
Related citations
Differential roles of endothelin-1 ETA and ETB receptors and vasoactive intestinal polypeptide in regulation of the airways and the pulmonary vasculature in isolated rat lung.
Janosi T, Peták F, Fontao F, Morel DR, Beghetti M, Habre W.
Exp Physiol. 2008 Nov;93(11):1210-9. Epub 2008 Jun 20.
Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
Yin J, Kukucka M, Hoffmann J, Sterner-Kock A, Burhenne J, Haefeli WE, Kuppe H, Kuebler WM.
Circ Heart Fail. 2011 Mar;4(2):198-206. Epub 2011 Jan 7. Erratum in: Circ Heart Fail. 2011 May 1;4(3):e13.
The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
Zeng Z, Li Y, Jiang Z, Wang C, Li B, Jiang W.
Cardiovasc Ther. 2010 Spring;28(1):23-9.
Precapillary pulmonary hypertension leads to reversible bronchial hyperreactivity in rats.
von Ungern-Sternberg BS, Habre W, Regli A, Pache JC, Fontao F, Janosi TZ, Beghetti M, Peták F.
Exp Lung Res. 2010 Apr;36(3):129-39.
Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
Liu H, Liu ZY, Guan Q.
Interact Cardiovasc Thorac Surg. 2007 Oct;6(5):608-13. Epub 2007 Jul 25.
Hypoxia-induced pulmonary hypertension: different impact of iloprost, sildenafil, and nitric oxide.
Weissmann N, Gerigk B, Kocer O, Nollen M, Hackemack S, Ghofrani HA, Schermuly RT, Butrous G, Schulz A, Roth M, Seeger W, Grimminger F.
Respir Med. 2007 Oct;101(10):2125-32. Epub 2007 Jul 20.
Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.
Casey DB, Badejo AM, Dhaliwal JS, Sikora JL, Fokin A, Golwala NH, Greco AJ, Murthy SN, Nossaman BD, Hyman AL, Kadowitz PJ.
Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H184-92. Epub 2010 Apr 30.
Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
Perez-Villa F, Farrero M, Sionis A, Castel A, Roig E.
J Heart Lung Transplant. 2010 Jul;29(7):817-8. Epub 2010 Apr 2. No abstract available.
Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension.
Rosengarten B, Schermuly RT, Voswinckel R, Kohstall MG, Olschewski H, Weissmann N, Seeger W, Kaps M, Grimminger F, Ghofrani HA.
Cerebrovasc Dis. 2006;21(3):194-200. Epub 2005 Dec 23.
Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N, Seeger W, Grimminger F.
Ann Intern Med. 2002 Apr 2;136(7):515-22.
Treatment of pulmonary arterial hypertension.
Humbert M, Sitbon O, Simonneau G.
N Engl J Med. 2004 Sep 30;351(14):1425-36. Review. No abstract available.
Pulmonary pressure reduction attenuates expression of proteins identified by lung proteomic profiling in pulmonary hypertensive rats.
Østergaard L, Honoré B, Thorsen LB, Baandrup J, Eskildsen-Helmond Y, Laursen BE, Vorum H, Mulvany MJ, Simonsen U.
Proteomics. 2011 Dec;11(23):4492-502. doi: 10.1002/pmic.201100171. Epub 2011 Oct 28.
Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia.
Luong C, Rey-Perra J, Vadivel A, Gilmour G, Sauve Y, Koonen D, Walker D, Todd KG, Gressens P, Kassiri Z, Nadeem K, Morgan B, Eaton F, Dyck JR, Archer SL, Thébaud B.
Circulation. 2011 May 17;123(19):2120-31. Epub 2011 May 2.
Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.
Hagan G, Pepke-Zaba J.
Expert Rev Respir Med. 2011 Apr;5(2):163-71. Review.
Endothelial dysfunction in the pulmonary vascular bed.
Chen YF, Oparil S.
Am J Med Sci. 2000 Oct;320(4):223-32. Review.
Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat.
Rossoni G, Manfredi B, De Gennaro Colonna V, Berti M, Guazzi M, Berti F.
Br J Pharmacol. 2007 Mar;150(5):567-76. Epub 2007 Jan 22.
Brain-derived neurotrophic factor enhances histamine-induced airway responses and changes levels of exhaled nitric oxide in guinea pigs in vivo.
Bennedich Kahn L, Gustafsson LE, Olgart Höglund C.
Eur J Pharmacol. 2008 Oct 24;595(1-3):78-83. Epub 2008 Jul 30.
Novel therapeutic approaches in pulmonary arterial hypertension: focus on tadalafil.
Levin YD, White RJ.
Drugs Today (Barc). 2011 Feb;47(2):145-56. Review.
[Sildenafil in neonate pulmonary hypertension: the opinion of neonatology physician].
Condò V, Colnaghi MR, Mosca E.
Pediatr Med Chir. 2008 May-Jun;30(3):156-8. Italian. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on